Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility-Reference-Cited by-同舟云学术

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility

Published:2012-11-20 Issue:12 Volume:107 Page:2076-2077
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:

Author:

Borry Pascal¹,Henneman Lidewij²

Affiliation:

1. Centre for Biomedical Ethics and Law; Katholieke Universiteit Leuven; Kapucijnenvoer 35, Box 7001; 3000; Leuven; Belgium

2. Department of Clinical Genetics, Section Community Genetics, EMGO Institute for Health and Care Research; VU University Medical Center; PO Box 7057; 1007 MB; Amsterdam; the Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1360-0443.2012.03939.x/fullpdf

Reference15 articles.

1. Direct-to-consumer genetic testing for addition susceptibility: a premature commercialisation of doubtful validity and value;Mathews;Addiction,2012

2. What is the clinical utility of genetic testing?;Grosse;Genet Med,2006

3. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions;Janssens;Am J Hum Genet,2008

4. Debating clinical utility;Burke;Public Health Genomics,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services;BMC Medical Ethics;2018-06-05

2. The value of genetic testing: beyond clinical utility;Genetics in Medicine;2017-07

3. Current Ethical Issues Related to the Implementation of Whole-Exome and Whole-Genome Sequencing;Movement Disorder Genetics;2015

4. Response to commentaries: Slowing down the rush to translation in personal genomics;Addiction;2012-11-20